Intraepithelial Effector (CD3+)/Regulatory (FoxP3+) T-Cell Ratio Predicts a Clinical Outcome of Human Colon Carcinoma
To access this article, please choose from the options below
Conflicts of interest The authors disclose no conflicts.
Funding Supported in part by National Cancer Institute grant CA104683-02 (to F.A.S.) and National Cancer Institute core grant CA15083 (to the Mayo Clinic Cancer Center).
PII: S0016-5085(09)01138-X
doi:10.1053/j.gastro.2009.06.053
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.

